Treatment of the hematological manifestations of dyskeratosis congenita
- PMID: 8485209
- DOI: 10.1007/BF01703237
Treatment of the hematological manifestations of dyskeratosis congenita
Abstract
Dyskeratosis congenita is a congenital multisystem disorder, characterized by skin pigmentation, dystrophic nails, and leukoplakia. Hematologic abnormalities progressing to severe pancytopenia play a significant role in the poor prognosis of afflicted patients. We report on a patient with dyskeratosis congenita and severe aplastic anemia, complicated by life threatening infection. The patient was treated with recombinant granulocyte-macrophage colony-stimulating factor. This therapy resulted in a moderate and transient improvement in absolute neutrophil counts. Current concepts regarding the pathogenesis and etiology of dyskeratosis congenita are discussed, while reviewing the available therapeutic options.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical